Cargando…
Outcomes of surgery and/or combination chemotherapy for extraskeletal osteosarcoma: a single-center retrospective study from China
Extraskeletal osteosarcoma (ESOS) is an extremely rare malignancy with poor prognosis, accounting for 2–4% of all osteogenic sarcomas. The purpose of this study was to examine the oncological outcomes of this disease related to surgical treatment and/or combined adjuvant therapies and to analyze the...
Autores principales: | Liao, Zhichao, Qiu, Minghan, Yang, Jilong, Yang, Yun, Zhu, Lei, Yang, Bo, Bai, Xu, Xing, Peipei, Zhang, Jin, Xing, Ruwei, Teng, Sheng, Zhao, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423283/ https://www.ncbi.nlm.nih.gov/pubmed/30886189 http://dx.doi.org/10.1038/s41598-019-41089-1 |
Ejemplares similares
-
Clinicopathologic features, prognostic factors, and outcomes of visceral sarcomas: A retrospective 12-year single-center study
por: Yang, Songwei, et al.
Publicado: (2022) -
Clinical study of apatinib in the treatment of stage IV osteogenic sarcoma after failure of chemotherapy
por: Liao, Zhichao, et al.
Publicado: (2020) -
Extraskeletal Osteosarcoma of the Orbit
por: Jacob, Rojymon, et al.
Publicado: (1998) -
Extraskeletal osteosarcoma in the back
por: Chang, Shu-Mei, et al.
Publicado: (2016) -
Chemotherapy Combined With Recombinant Human Endostatin (Endostar) Significantly Improves the Progression-Free Survival of Stage IV Soft Tissue Sarcomas
por: Liao, Zhichao, et al.
Publicado: (2022)